After receiving a BSc in Biological Sciences from Edinburgh University in 1978 and a PhD from University College London in 1982 for studies carried out at the Imperial Cancer Research Fund (now Cancer Research UK), Tom Curran moved to the United States. Working in industry and academia, his research spans the fields of cancer, signal transduction, brain development and neurobiology. He developed a particular interest in translating scientific discoveries into medical advances for children. His work contributed to a new cancer treatment that shows promise in pediatric brain tumors and was approved for advanced basal cell carcinoma. Currently, he is building a new pediatric research institute in Kansas City, Missouri.